from Reuters: Technology News https://ift.tt/2YAnwKn
Thursday, August 1, 2019
Chinese drugmaker Chipscreen's STAR Market IPO sees feverish demand
Shenzhen Chipscreen Biosciences, which plans to list on China's red-hot new tech board, said its newly issued shares were almost 3,000-times oversubscribed among retail investors, despite an eye-popping offer pricing of 468-times earnings.
from Reuters: Technology News https://ift.tt/2YAnwKn
from Reuters: Technology News https://ift.tt/2YAnwKn
Subscribe to:
Post Comments (Atom)
-
Facebook’s Zuckerberg blasted for ‘out of touch’ year-end post after scandal-plagued 2018 After a year plagued by privacy scandals, hat...
-
iCOPS will deliver a unified management experience across hybrid and multi-cloud operations with a focus on enhancing compliance and securit...
No comments:
Post a Comment